J. Yang

Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China: Time to reach target glucose.

S. Lee, Y. Mu, T. Cordero, 2017, Diabetes & metabolism.

Efficacy and safety of liraglutide versus sitagliptin, both in combination with metformin, in Chinese patients with type 2 diabetes: a 26‐week, open‐label, randomized, active comparator clinical trial

X. Lv, Y. Li, L. Zang, 2016, Diabetes, obesity & metabolism.

Activation of glucagon‐like peptide‐1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway

T. Hong, R. Wei, T. Hong, 2014, Diabetes, obesity & metabolism.

AI-based Model CRM to Evaluate the Responses of Breast Cancer Patients to CDK4/6 Inhibitors-Based Therapies and Simulate Real-World Clinical Trials

C. Zhang, J. Xu, G. Niu, 2023, medRxiv.